{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:25:01Z","timestamp":1793741101534,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.redox.2019.101315","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:23:25Z","timestamp":1567538605000},"page":"101315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling"],"prefix":"10.1016","volume":"28","author":[{"given":"Mi Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Bae","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Chul","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Shik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.redox.2019.101315_bib1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/07315724.2012.10720004","article-title":"Probiotics in the treatment of the liver diseases","volume":"31","author":"Kirpich","year":"2012","journal-title":"J. Am. Coll. Nutr."},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/10408398.2014.952399","article-title":"The potential of flavonoids in the treatment of non-alcoholic fatty liver disease","volume":"57","author":"Van De Wier","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"6","key":"10.1016\/j.redox.2019.101315_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1467-789X.2009.00657.x","article-title":"Non-alcoholic fatty liver disease from pathogenesis to management: an update","volume":"11","author":"Musso","year":"2010","journal-title":"Obes. Rev.: Off. J. Int. Assoc. Study Obes."},{"issue":"15\u201316","key":"10.1016\/j.redox.2019.101315_bib5","first-page":"1297","article-title":"The role of oxidative stress in non-alcoholic steatohepatitis, Clinica chimica acta","volume":"412","author":"Koek","year":"2011","journal-title":"Int. J. Clin. Chem."},{"issue":"6","key":"10.1016\/j.redox.2019.101315_bib6","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/hep.510270601","article-title":"Hepatic steatosis: innocent bystander or guilty party?","volume":"27","author":"Day","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2019.101315_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/bj3460659","article-title":"Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding","volume":"346 Pt 3","author":"Cheung","year":"2000","journal-title":"Biochem. J."},{"issue":"Pt 23","key":"10.1016\/j.redox.2019.101315_bib8","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1242\/jcs.01540","article-title":"The AMP-activated protein kinase pathway--new players upstream and downstream","volume":"117","author":"Hardie","year":"2004","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1172\/JCI34973","article-title":"From fatty streak to fatty liver: 33 years of joint publications in the JCI","volume":"118","author":"Goldstein","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"27","key":"10.1016\/j.redox.2019.101315_bib10","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.redox.2019.101315_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101137","article-title":"Non-alcoholic fatty liver disease and nutritional implications: special focus on copper","volume":"9","author":"Antonucci","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.redox.2019.101315_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jnutbio.2011.09.006","article-title":"The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease","volume":"23","author":"Nomura","year":"2012","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.redox.2019.101315_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2017.12.019","article-title":"Mitochondria in non-alcoholic fatty liver disease","volume":"95","author":"Simoes","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.redox.2019.101315_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.biopha.2017.01.114","article-title":"Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice","volume":"88","author":"Jeong","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.redox.2019.101315_bib17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s11427-016-9027-6","article-title":"Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1, Science China","volume":"60","author":"Geng","year":"2017","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0968-0004(02)00003-8","article-title":"Structure, mechanism and regulation of peroxiredoxins","volume":"28","author":"Wood","year":"2003","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.redox.2019.101315_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.bbagen.2013.08.001","article-title":"Peroxiredoxins as biomarkers of oxidative stress","volume":"1840","author":"Poynton","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.redox.2019.101315_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/ars.2010.3766","article-title":"Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression","volume":"16","author":"Huh","year":"2012","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2019.101315_bib21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.freeradbiomed.2016.08.030","article-title":"Peroxiredoxin 5 (Prx5) decreases LPS-induced microglial activation through regulation of Ca(2+)\/calcineurin-Drp1-dependent mitochondrial fission","volume":"99","author":"Park","year":"2016","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2019.101315_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.freeradbiomed.2018.05.061","article-title":"Peroxiredoxin 5 regulates adipogenesis-attenuating oxidative stress in obese mouse models induced by a high-fat diet","volume":"123","author":"Kim","year":"2018","journal-title":"Free Radical Biol. Med."},{"issue":"2","key":"10.1016\/j.redox.2019.101315_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"Gomez-Lechon","year":"2007","journal-title":"Chem. Biol. Interact."},{"issue":"Pt 7","key":"10.1016\/j.redox.2019.101315_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1099\/0022-1317-72-7-1551","article-title":"Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics","volume":"72","author":"Southern","year":"1991","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.theriogenology.2009.07.028","article-title":"Real-time in vivo bioluminescence imaging of lentiviral vector-mediated gene transfer in mouse testis","volume":"73","author":"Kim","year":"2010","journal-title":"Theriogenology"},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.22710","article-title":"c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps","volume":"49","author":"Kodama","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.redox.2019.101315_bib27","first-page":"1624","article-title":"Signal transductions and nonalcoholic fatty liver: a mini-review","volume":"7","author":"Zeng","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.redox.2019.101315_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2014.00071","article-title":"Regulation of the NF-kappaB-Mediated transcription of inflammatory genes","volume":"5","author":"Bhatt","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1373\/clinchem.2006.081257","article-title":"Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease","volume":"53","author":"Chang","year":"2007","journal-title":"Clin. Chem."},{"issue":"13","key":"10.1016\/j.redox.2019.101315_bib30","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1089\/ars.2012.4599","article-title":"Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling","volume":"19","author":"Hanschmann","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"2","key":"10.1016\/j.redox.2019.101315_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/mmr.2012.935","article-title":"Measurement of peroxiredoxin-4 serum levels in rat tissue and its use as a potential marker for hepatic disease","volume":"6","author":"Ito","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"17","key":"10.1016\/j.redox.2019.101315_bib32","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/ars.2012.4946","article-title":"Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model","volume":"19","author":"Nabeshima","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152549","article-title":"Overexpression of peroxiredoxin 4 affects intestinal function in a dietary mouse model of nonalcoholic fatty liver disease","volume":"11","author":"Nawata","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.redox.2019.101315_bib34","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.2337\/db14-0144","article-title":"Peroxiredoxin 6, a novel player in the pathogenesis of diabetes","volume":"63","author":"Pacifici","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2015.08.008","article-title":"PRDX1 is involved in palmitate induced insulin resistance via regulating the activity of p38MAPK in HepG2 cells","volume":"465","author":"Tang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.redox.2019.101315_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pin.12634","article-title":"Peroxiredoxin 4 (PRDX4): its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease","volume":"68","author":"Yamada","year":"2018","journal-title":"Pathol. Int."},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2019.101315_bib38","first-page":"2005","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases","volume":"55","author":"Chalasani","year":"2012","journal-title":"Am. Coll. Gastroenterol. Am. Gastroenterol. Assoc. Hepatol."},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"15","key":"10.1016\/j.redox.2019.101315_bib40","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.2174\/1381612811319150009","article-title":"Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD)","volume":"19","author":"Podrini","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1179\/1351000213Y.0000000050","article-title":"The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis","volume":"18","author":"Ucar","year":"2013","journal-title":"Redox Rep.: Commun. Free Radic. Res."},{"issue":"16","key":"10.1016\/j.redox.2019.101315_bib42","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.redox.2019.101315_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"issue":"39","key":"10.1016\/j.redox.2019.101315_bib44","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.3748\/wjg.v16.i39.4932","article-title":"HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN\/Akt pathway","volume":"16","author":"Ha","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"42","key":"10.1016\/j.redox.2019.101315_bib45","doi-asserted-by":"crossref","first-page":"31713","DOI":"10.1016\/S0021-9258(19)84085-1","article-title":"CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice","volume":"281","author":"Uchiyama","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.redox.2019.101315_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.redox.2019.101315_bib48","first-page":"E730","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK, American journal of physiology","volume":"311","author":"Smith","year":"2016","journal-title":"Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.redox.2019.101315_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/MCB.00503-14","article-title":"Hepatic mitogen-activated protein kinase phosphatase 1 selectively regulates glucose metabolism and energy homeostasis","volume":"35","author":"Lawan","year":"2015","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.redox.2019.101315_bib50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.tem.2017.10.007","article-title":"Mitogen-activated protein kinase regulation in hepatic metabolism","volume":"28","author":"Lawan","year":"2017","journal-title":"Trends Endocrinol. Metab.: TEM (Trends Endocrinol. Metab.)"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719308079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719308079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:17:46Z","timestamp":1761977866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231719308079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":50,"alternative-id":["S2213231719308079"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2019.101315","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2019.101315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101315"}}